Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
0.9140
-0.0359 (-3.78%)
At close: Mar 11, 2026, 4:00 PM EDT
0.9100
-0.0040 (-0.44%)
After-hours: Mar 11, 2026, 7:12 PM EDT

Revenue by Segment

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Pipeline Research and Development (Pipeline R&D)
381.00K699.00K578.00K343.00K674.00K
Pipeline Research and Development (Pipeline R&D) Growth
-45.49%20.93%68.51%-49.11%-65.22%
Total
381.00K699.00K578.00K343.00K674.00K
Total Growth
-45.49%20.93%68.51%-49.11%-65.22%

Revenue by Geography

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Belgium
381.00K699.00K578.00K114.00K-
Belgium Growth
-45.49%20.93%407.02%--
United Kingdom
---4.00K197.00K
United Kingdom Growth
----97.97%32.21%
Rest of The World
---62.00K60.00K
Rest of The World Growth
---3.33%-
Rest of Europe
----55.00K
Total
381.00K699.00K578.00K180.00K312.00K
Total Growth
-45.49%20.93%221.11%-42.31%109.40%
Source: S&P Global Market Intelligence.